Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.
Acknowledgment of Commercial Support
This activity is supported by educational grants from Phathom Pharmaceuticals.
Advances In™ Overcoming Barriers to Diagnosis and Treatment of Helicobacter pylori Infections
Release Date: November 12, 2021
Expiration Date: November 12, 2022
Activity Overview
Acknowledgement of Commercial Support
This activity is supported by an educational grant from Phathom Pharmaceuticals.
Instructions for This Activity and Receiving Credit
You may immediately download your certificate. |
Target Audience
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Identify appropriate patients who should undergo testing for H. pylori infection.
- Describe strategies to overcome current challenges to the successful eradication of H. pylori infection.
- Apply evidence and patients' medical history, including antibiotic use, to the selection of appropriate therapies for H. pylori infection.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
Faculty

Professor Emeritus
University of Tennessee College of Medicine
Memphis, TN
Disclosures: Consultant: Phathom Pharmaceuticals, RedHill Biopharma, Ironwood Pharmaceuticals, Allakos, Alfasigma Pharmaceuticals, Clexio Biosciences. Speaker’s Bureau: Alnylam, RedHill Biopharma. Stock/Shareholder: Antibe Therapeutics.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
Login or Register to Start Activity
Please use the form below to Register or Log In to begin Activity.